LIVE NEWS
  • The best note-taking apps for iPad of 2026: Expert tested
  • Analysis: Why clean energy will cut UK gas imports by more than North Sea drilling
  • Utah’s anti-gambling tradition meets Kalshi and Polymarket in a new legal fight
  • Leucovorin, Jeffrey Epstein, Novo, FDA: Readout Newsletter
  • Google Play Games for PC is getting more premium titles and cross-buy with Android
  • Liza Tarbuck leaves Radio 2 Saturday show after 14 years
  • Building physical AI with virtual simulation data
  • Watchdog weighs action against countries missing UN climate plan
Prime Reports
  • Home
  • Popular Now
  • Crypto
  • Cybersecurity
  • Economy
  • Geopolitics
  • Global Markets
  • Politics
  • See More
    • Artificial Intelligence
    • Climate Risks
    • Defense
    • Healthcare Innovation
    • Science
    • Technology
    • World
Prime Reports
  • Home
  • Popular Now
  • Crypto
  • Cybersecurity
  • Economy
  • Geopolitics
  • Global Markets
  • Politics
  • Artificial Intelligence
  • Climate Risks
  • Defense
  • Healthcare Innovation
  • Science
  • Technology
  • World
Home»Healthcare Innovation»Leucovorin, Jeffrey Epstein, Novo, FDA: Readout Newsletter
Healthcare Innovation

Leucovorin, Jeffrey Epstein, Novo, FDA: Readout Newsletter

primereportsBy primereportsMarch 12, 2026No Comments1 Min Read
Share Facebook Twitter Pinterest LinkedIn Tumblr Reddit Telegram Email
Leucovorin, Jeffrey Epstein, Novo, FDA: Readout Newsletter
Share
Facebook Twitter LinkedIn Pinterest Email


Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Good morning. We’ve got a lot of news and deep dives today, so let’s get straight to it.

A top VC helped Epstein’s friend make a comeback

The biotech industry appeared to distance itself from investor Boris Nikolic after his friendship with Jeffrey Epstein came to light in 2019. But in the following years, one of the most influential biotech venture capitalists, Alexis Borisy, quietly shepherded a comeback for Nikolic, my colleague Damian Garde reports in a new exclusive.

STAT+ Exclusive Story

Already have an account? Log in

Leucovorin, Jeffrey Epstein, Novo, FDA: Readout Newsletter



STAT+

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Previous ArticleGoogle Play Games for PC is getting more premium titles and cross-buy with Android
Next Article Utah’s anti-gambling tradition meets Kalshi and Polymarket in a new legal fight
primereports
  • Website

Related Posts

Healthcare Innovation

Scientists may have found a pill for sleep apnea

March 12, 2026
Healthcare Innovation

HIMSS26: Strengthen the Muscle of AI Strategy With Clinical Insight

March 11, 2026
Healthcare Innovation

GOP Sen. Johnson investigating FDA rare disease drug rejections

March 11, 2026
Add A Comment
Leave A Reply Cancel Reply

Top Posts

Global Resources Outlook 2024 | UNEP

December 6, 20255 Views

The D Brief: DHS shutdown likely; US troops leave al-Tanf; CNO’s plea to industry; Crowded robot-boat market; And a bit more.

February 14, 20264 Views

German Chancellor Merz faces difficult mission to Israel – DW – 12/06/2025

December 6, 20254 Views
Stay In Touch
  • Facebook
  • YouTube
  • TikTok
  • WhatsApp
  • Twitter
  • Instagram
Latest Reviews

Subscribe to Updates

Get the latest tech news from FooBar about tech, design and biz.

PrimeReports.org
Independent global news, analysis & insights.

PrimeReports.org brings you in-depth coverage of geopolitics, markets, technology and risk – with context that helps you understand what really matters.

Editorially independent · Opinions are those of the authors and not investment advice.
Facebook X (Twitter) LinkedIn YouTube
Key Sections
  • World
  • Geopolitics
  • Artificial Intelligence
  • Popular Now
  • Cybersecurity
  • Crypto
All Categories
  • Artificial Intelligence
  • Climate Risks
  • Crypto
  • Cybersecurity
  • Defense
  • Economy
  • Geopolitics
  • Global Markets
  • Healthcare Innovation
  • Politics
  • Popular Now
  • Science
  • Technology
  • World
  • About Us
  • Contact Us
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
  • Cookie Policy
  • DMCA / Copyright Notice
  • Editorial Policy

Sign up for Prime Reports Briefing – essential stories and analysis in your inbox.

By subscribing you agree to our Privacy Policy. You can opt out anytime.
Latest Stories
  • The best note-taking apps for iPad of 2026: Expert tested
  • Analysis: Why clean energy will cut UK gas imports by more than North Sea drilling
  • Utah’s anti-gambling tradition meets Kalshi and Polymarket in a new legal fight
© 2026 PrimeReports.org. All rights reserved.
Privacy Terms Contact

Type above and press Enter to search. Press Esc to cancel.